跳至主要内容
临床试验/NCT01125436
NCT01125436已完成不适用

A Randomized Placebo Controlled Trial of Vitamin D Therapy in Patients With Heart Failure

Case Western Reserve University1 个研究点 分布在 1 个国家目标入组 64 人开始时间: 2008年7月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
64
试验地点
1
主要终点
Peak VO2

研究概览

简要总结

The purpose of this study is to determine if vitamin D will improve physical performance in older adults with heart failure.

详细描述

The study is designed as a short pilot study which will assess safety and efficacy of high dose Vitamin D therapy in a heart failure population.

A 6 month randomized double blind placebo-controlled trial of 50,000 units of oral vitamin D3(cholecalciferol) weekly plus 800 calcium daily vs. weekly placebo plus 800 calcium alone in 64 heart failure (HF) patients > 50 years old. This design was chosen over a cross-over design due to the long wash-out period for vitamin D.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •New York Heart Association (NYHA) class II-IV
  • •Able to walk
  • •Serum 25OHD level 37.5 ng/ml or less
  • •Fully titrated on heart failure medications

排除标准

  • •Osteoporosis
  • •Primary hyperparathyroidism or hypercalcemia.
  • •Nephrolithiasis
  • •Hemo or peritoneal dialysis and/or creatinine of > 2.5
  • •Current use of daily vitamin D greater than 400 IU, corticosteroids, parathyroid hormone (PTH), androgen or estrogen
  • •Current illicit drug user or > 3 alcoholic drinks a day
  • •Metastatic or advanced cancer
  • •Myocardial infarction in the preceding 6 months
  • •Medications which can lower vitamin D levels or bioavailability

研究组 & 干预措施

Cholecalciferol

Experimental

Nutritional supplement

干预措施: Cholecalciferol (Dietary Supplement)

placebo

Placebo Comparator

Weekly placebo plus 800 calcium daily

干预措施: Cholecalciferol (Dietary Supplement)

结局指标

主要结局

Peak VO2

时间窗: change from baseline to 6 months

Cardiopulmonary stress testing with the Peak VO2 representing maximal aerobic capacity

次要结局

  • Leg Proximal Muscle Strength(change from baseline to 6 months)
  • 6 Minute Walk Distance(Change from baseline to 6 months)
  • Timed Get Up and Go(Change from baseline to 6 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验